Cryo-Cell International Inc. (CCEL) is a publicly traded Healthcare sector company. As of July 15, 2026, CCEL trades at $3.54 with a market cap of $27.39M and a P/E ratio of -11.82. CCEL moved +5.15% today. Year to date, CCEL is +5.15%; over the trailing twelve months it is -24.74%. Its 52-week range spans $2.72 to $9.10. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces CCEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CCEL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CCEL recently traded at $3.54. Market cap is $27.39M. P/E ratio is -11.82. Revenue is $31.57M.
| Metric | Value |
|---|---|
| Price | $3.54 |
| Market Cap | $27.39M |
| P/E Ratio | -11.82 |
| EPS | $-0.30 |
| Dividend Yield | 0.15% |
| 52-Week High | $9.10 |
| 52-Week Low | $2.72 |
| Volume | 15.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $31.57M |
| Net Income | $-2.43M |
| Gross Margin | 76.63% |
1 analysts cover CCEL: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.